Summary: This paper describes a fully mechanized homogeneous immunoassay using the immunoactivation method for the rapid and specific determination of human granulocyte elastase (EC 3.4.21.37) in plasma. The method uses anti-elastase antibody Fragments from sheep, conjugated to horseradish peroxidase. These enzymeantibody conjugates bind to the elastase-a r proteinase inhibitor complex present in plasma. A separate sample blank with non-specific sheep antibody fragments conjugated to horseradish peroxidase corrects for errors introduced by the sample matrix. Measurements were performed with the clinical chemistry analyser Hitachi® 717. A single determination can be performed in 10 min, requiring 24 μΐ sample volume. The measuring r nge is about 20 to 1000 μg/l elastase. For within-run precision the coefficients of Variation are 4.77%, 4.48% and 1.85% for elastase concentrations of 45.7, 89.1 and 385.4 μg/l; for day-to-day precision the coefficients of Variation are 15.81%, 7.19% and 4.12% for elastase concentrations of 31.1, 65.5 and 440.2 μ §/1, respectively. Correlation (y = bx + a) of results with those from the heterogeneous immunoassay showed a good agreement (r = 0.93, b = 1.11, a == -27.0, N = 121). Interferencesby endogeneous substances and by drugs at therapeutic doses were not observed. The reference interval, determined by using plasma from 215 healthy individuals (C-reactive protein < 5 itig/1, leukocyte count 4-8 χ 10 9
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A Sandwich ELISA for the determination of elastase (E. Merck, Darmstadt, Germany) was used for method comparison. The calibrators of this heterogeneous assay, formerly containing only about !/ 3 of the given elastase content, are now based on and recalibrated to (from batch #92019 onward) the same highly purified Standard material also used in the PMN Elastase IMAC immunoassay.
As sample material, sodium citrate plasma (38. g sodium citrate per litre in the ratio l part citrate to 9 parts blood) was obtained by venipuncture. The plasma was separated by centrifuging at 1700g for 10 min at room temperature. Samples which were not measured immediately were stored in plastic Containers at -70 °C. All dilution of samples was performed with the IMAC sample dilution medium (E. Merck, Darmstadt, Germany).
C-reactive protein was determined in sodium citrate plasma on the Behring nephelometer analyser (Behring, Marburg, Germany). The reagent used was the NA Latex CRP Reagent (Behring, Marburg, Germany). In this assay polystyrene particles coated with antibodies to C-reactive protein are agglutinated by C-reactive protein in the patients' plasma. The scattered light signal obtained on the Behring nephelometer increases in relation to the concentration of C-reactive protein (measurement r nge: 2.5-160 mg/1, reference r nge for adults: < 10 mg/1). The white blood cells were counted using K-EDTA whole blood on the S-plus counter (Coulter, Luton, UK; reference r nge: 4-10 χ 10 9 /1).
Results
The test of linearity by serial dilution of a pooled plasma showed a dependence on the concentration of the calibrator. The lines in figure l show that after calibration with high calibrator concentrations the calculated regression lines (19) deviate only slightly from the origin. The method was tested by comparing the immunoactivation test on the Hitachi® analyser with the commercial heterogeneous enzyme-iinked immunosorbent assay ( fig. 2 ). The evaluation of the results according to a distribution-free regression analysis (19) showed a good correlation (y = bx + a;b = 1.11, a = -27.9, r = 0.93, N = 121). Older batches of the heterogeneous assay yielded concentrations 3 times higher than those given by the IMAC assay. After conversion of the ELISA calibrators for the highly purified raw materials also used in the immunoactivation assay, and recalibration of the heterogeneous assay, similar results were obtained with both tests. Analysis of lipaemic and haemolytic samples revealed that lipaemic samples with triacylglycerol concentrations p to 5 g/l and haemolytic samples with a free haemoglobin concentration up to l g/l in the plasma do not influence result. The same holds for hyperbilirubinaemia (plasma concentrations up to 510 μιηοΐ/l bilkubin). However, it must be noted that there is a lag phase in the time course of absorbance. This is the reason why we have chosen measurement points 35 -41 when adjusting the pafameters ( fig. 3 ). Ascorbic acid in concentrations appreciably higher than physiological levels (after administration of multivitamin infusions) also causes noticeable interference. A possible explanation for this is that primary oxidation products of the Substrate are rapidly reduced by the ascorbic acid (17 To establish a reference r nge, citrate plasma samples were measured from 215 healthy adults (93 women, 122 men) aged 18 to 60 years with a C-reactive protein concentration < 10 mg/1 and a leukocyte count of 4-10 χ 10 9 /1 (fig-4) . The median was 27 μg/l and the reference r nge was 9 to 56 μg/l (2. 
Discussion
The availability of suitable markers for the early diagnosis of complications in the course of inflammatory processes facilitates more rapid and rational therapeutic treatment. Due to the fact that these parameters are in the §/1 ränge or lower, heterogeneous assays have been the methods of choice. However, these techniques are rather time-consuming and not really suitable for an emergency. The new immunoactivation technique offers the advantage of a determination of elastase in the plasma in less than 15 min. The test principle is based on the known fact that hydrogen peroxide converts monomeric forms of horseradish peroxidase via the active intermediate stages compound I and compound II into the enzymatically less active compound III. The oxidation states and coordination geometrics of the different species have been elucidated by spectrophotometric and X-ray diffraction experiments (21) . The native enzyme is regenerated by the reaction of compound III with electron donors (e. N g. phenol) via the intermediate stages compound I and compound II. Depending on the nature of the Substrate, high H 2 O 2 concentrations can lead to an accumulation of compound III and thus to a strongly decreased enzymatic activity of monomeric horseradish peroxidase. In the case of polymerized or aggregated horseradish peroxidase, a much lower accumulation of compound III is observed under the same conditions, so that the enzymatic activity is appreciably higher (17, 18) . This phenomenon, which is not yet clear in detail, forms the basis of the immunoactivation method. By linking anti-elastase antibody fragments to horseradish peroxidase, monomeric conjugates are obtained, which have a low enzymatic activity in the presence of a mixture of the Substrates phenol and 4-aminophenazone, äs well äs a high concentration of hydrogen peroxide. If the monomeric conjugates first react with elastase from the sample, high-molecular immunoaggregates appear, with appreciably higher enzyme activity. The elastase concentration in the sample is directly proportional to the increase in enzymatic activity. All horseradish peroxidase effectors and substances that exert intrinsic peroxidase activity are potentially capable of interfering. These disturbances are compensated by the use of ä special blank conjugate, so that influence of the sample matrix can be corrected (15, 16) .
To perform the homogeneous assay on clinical chemistry analysers, it is necessary to occupy two channels (sample and blank). There is a linear relationship between the elastase concentration and the enzymatic activity of the antibody conjugate after complexing:
this is determined by a 2-point calibration (Standard 1: §/1, Standard 2: 398 g/l). In accordance with the nature of the blank conjugate, which is incapable of forming immunoaggregates and thus shows no dependence on the measurement signal from the Standard concentration, the blank channel cannot be calibrated in a similar way. To ijiake it possible to base both channels on an identical linear calibration, the factor for the sample channel obtained from the Instrument is therefore used for the blank channel. The reagent blank value of the blank conjugate is then determined. Using this type of calibration ensures that both channels can assign the same measurement Signals to the same concentration values. Interfering influences of the sample matrix, which cause identical modification of the measurement Signal in both channels, can now be eliminated by simply subtracting the concentration values of one channel from those of the other.
Free elastase does not occur in the plasma. It immediately forms complexes with inhibitor, which is present in large excess in the plasma but not in the tissues. In addition to the elastase complexed with the ap roteinase inhibitor in the plasma, there is a small fraction consisting of a complex with the a 2 -macroglobulin (total fraction < 10%) (13, 14) . This complex does not bind with the antibody conjugate of the homogeneous test (Dreher, M., unpublished data), For this reason, for plasma, the specificity of the test does not differ from that of the heterogeneous ELISA, which has been used üp to now.
The latter is a typical sandwich immunoassay utilizing antibodies directed against elastase and ot a -proteinase inhibitor (22) . A comparison of both methods shows a good correlation. The within-run precision and dayto-day precision show coefficients of Variation that are typical of tests performed on analysers. The linearity over the extended measurement ränge (up to 1000 g/l) requires additional dilution only in rare cases of massive elastase release. Apart from a few extreme cases (e. g. high bilirubin, high ascorbic acid), no false results have been found. No carry-over effects of the reagent on the analyser could be detected. On the basis of the long stability of the reagent. and the· satisfactory stability of the sample in vitro without special sample collection and work-up, the determination method is suitable for emergency testing.
Conclusion
The determination of elastase/a^protemase inhibitor complex in the plasma is a sensitive, precise routine assay, linear over a wide ränge of measurement, which Eur. J. Clin. Chera. Clin. Biochem. / Vol. 29,1991 / No. 3 can bc performed in less than 15 min on the Hitachi® 717 automated analyser without special treatment of the sample.
